Quantcast

Latest Novartis Stories

2014-08-19 04:22:39

JERUSALEM, August 19, 2014 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com ], a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG [http://www.novartis.com ] ("Novartis"). According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable...

2014-08-18 23:00:25

Georgina Wood is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession Garden City, NY (PRWEB) August 19, 2014 NAPW honors Georgina Wood as a 2014 Professional Woman of the Year. Ms. Wood is recognized with this prestigious distinction for leadership in pharmaceuticals. As the largest, most-recognized networking organization of professional women in the country, spanning virtually every industry and profession, the National...

2014-08-14 12:28:24

DALLAS, August 14, 2014 /PRNewswire/ -- LifeScienceIndustryResearch.com offers Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global Forecast to 2018 research report in its store. It says global animal vaccines market is in its growth phase and is poised to cross the $8 billion mark by...

2014-08-12 16:27:31

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders....

2014-08-12 08:29:26

Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Ron Squarer, Chief Executive Officer of Array, noted, "The Array-invented MEK inhibitors, binimetinib and selumetinib, are currently enrolling six Phase 3 trials, and each of our partners has...

2014-08-11 12:28:18

Twenty-five pharmaceutical companies being asked to adopt common principles re biosimilars on patient safety, lobbying and business partnerships. DETROIT, Aug. 11, 2014 /PRNewswire/ -- A coalition of 19 institutional investors representing $430 billion in assets commends Amgen and Novartis for support of a set of investor principles to guide corporate boards on policy and oversight responsibilities related to biosimilar activities. The principles, included in the coalition's Investor...

2014-08-11 12:27:45

AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer, Sanofi, Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc. ELLICOTT CITY, Md., Aug. 11, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing...

2014-08-11 00:20:49

-- LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF EAST HANOVER, N.J., Aug. 11, 2014 /PRNewswire/ -- New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday...

2014-07-25 08:25:20

DUBLIN, July 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Nicotine Gum Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. Nicotine...

2014-07-23 23:17:53

MarketReportsOnline.com adds "Global Molecular Diagnostics Market Report: 2014 Edition" report to its research store. Dallas, Texas (PRWEB) July 22, 2014 Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.